Observational studyBMC public health2023

A prospective cohort study protocol: monitoring and surveillance of adverse events following heterologous booster doses of Oxford AstraZeneca COVID-19 vaccine in previous recipients of two doses of Sinopharm or Sputnik V vaccines in Iran.

Shahin Soltani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.